US Patent Issued to BIOVERATIV THERAPEUTICS on June 16 for "Factor IX polypeptide formulations" (Massachusetts Inventor)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,653,871, issued on June 16, was assigned to BIOVERATIV THERAPEUTICS INC. (Waltham, Mass.).

"Factor IX polypeptide formulations" was invented by Mark Brader (Lexington, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides formulations comprising a Factor IX-FcRn Binding Partner (FIXFBP) polypeptide, and methods of administering FIXFBP."

The patent was filed on March 16, 2023, under Application No. 18/184,821.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1...